UPenn sues Genentech over patent infringement with four cancer drugs

The University of Pennsylvania is suing Roche’s Genentech again, this time seeking an unidentified amount of damages for infringing on a Penn patent that’s linked to four of the California biotech’s cancer treatments and which has helped bring in billions in sales over the years. The patent in question from…

...

Click to view original post